SEC Company Response from Goosehead Insurance, (GSHD) — Apr 24, 2018
Goosehead Insurance, Inc.
Date: April 24, 2018 · CIK: 0001726978 · Accession: 0001193125-18-129465
AI Filing Summary & Sentiment
File numbers found in text: 333-224080
Referenced dates: February 13, 2018
Letter
Division of Corporation Finance Office of Healthcare and Insurance U.S. Securities and Exchange Commission 100 F Street, N.E. Washington, DC 20549-3628
Dear Ms. Breslin and Mr. Edwards:
On behalf of our client, Goosehead Insurance, Inc., a Delaware corporation (the “Company”), we are responding to a comment from the Staff (the “Staff”) of the Securities and Exchange Commission (the “Commission”) relating to the Company’s Registration Statement on Form S-1 (the “Registration Statement”) contained in the Staff’s letter dated February 13, 2018 (the “Comment Letter”).
Set forth below is the Company’s responses to the Staff’s comment. For convenience, the Staff’s comment is repeated below in italics, followed by the Company’s response to the comment.
Description on capital stock, page 125
1. Once you have an estimated offering price or range, please explain to us how you determined the fair value of the common stock underlying your equity issuances and the reasons for any differences between the recent valuations of your common stock leading up to the initial public offering and the estimated offering price. This information will help facilitate our review of your accounting for equity issuances including stock compensation and beneficial conversion features.
Ms. Mary Beth Breslin
Mr. Chris Edwards
Division of Corporation Finance
Office of Healthcare and Insurance
U.S. Securities and Exchange Commission
April 24, 2018
Response:
The Company respectfully advises the Staff that Goosehead Financial, LLC has not made any equity grants since January 1, 2016 other than incentive grants of Class B units. These grants are perpetually unvested (meaning they are forfeited upon a termination of employment) and are not considered to be a substantive class of equity under Accounting Standards Codification (“ASC”) 718. Therefore, pursuant to ASC 718, Goosehead Financial, LLC did not recognize compensation expense on account of these grants. As such, the Company respectfully advises that there was no valuation used at the time of the grant of such equity awards with which to compare to the mid-point of the price range per share in the offering.
Should any questions arise, please do not hesitate to contact me at (212) 450-4674 (tel), (212) 701-5674 (fax) or richard.truesdell@davispolk.com. Thank you for your time and attention.
Very truly yours,
/s/ Richard D. Truesdell, Jr.
Show Raw Text
CORRESP 1 filename1.htm Cheap Stock Response Letter New York Northern California Washington DC São Paulo London Paris Madrid Tokyo Beijing Hong Kong Richard D. Truesdell, Jr. Davis Polk & Wardwell LLP 450 Lexington Avenue New York, NY 10017 212 450 4674 tel 212 701 5674 fax richard.truesdell@davispolk.com April 24, 2018 Re: Goosehead Insurance, Inc. Amendment No. 2 to Registration Statement on Form S-1 Submitted April 17, 2018 Registration No. 333-224080 CONFIDENTIAL Ms. Mary Beth Breslin Mr. Chris Edwards Division of Corporation Finance Office of Healthcare and Insurance U.S. Securities and Exchange Commission 100 F Street, N.E. Washington, DC 20549-3628 Dear Ms. Breslin and Mr. Edwards: On behalf of our client, Goosehead Insurance, Inc., a Delaware corporation (the “Company”), we are responding to a comment from the Staff (the “Staff”) of the Securities and Exchange Commission (the “Commission”) relating to the Company’s Registration Statement on Form S-1 (the “Registration Statement”) contained in the Staff’s letter dated February 13, 2018 (the “Comment Letter”). Set forth below is the Company’s responses to the Staff’s comment. For convenience, the Staff’s comment is repeated below in italics, followed by the Company’s response to the comment. Description on capital stock, page 125 1. Once you have an estimated offering price or range, please explain to us how you determined the fair value of the common stock underlying your equity issuances and the reasons for any differences between the recent valuations of your common stock leading up to the initial public offering and the estimated offering price. This information will help facilitate our review of your accounting for equity issuances including stock compensation and beneficial conversion features. Ms. Mary Beth Breslin Mr. Chris Edwards Division of Corporation Finance Office of Healthcare and Insurance U.S. Securities and Exchange Commission April 24, 2018 Response: The Company respectfully advises the Staff that Goosehead Financial, LLC has not made any equity grants since January 1, 2016 other than incentive grants of Class B units. These grants are perpetually unvested (meaning they are forfeited upon a termination of employment) and are not considered to be a substantive class of equity under Accounting Standards Codification (“ASC”) 718. Therefore, pursuant to ASC 718, Goosehead Financial, LLC did not recognize compensation expense on account of these grants. As such, the Company respectfully advises that there was no valuation used at the time of the grant of such equity awards with which to compare to the mid-point of the price range per share in the offering. Should any questions arise, please do not hesitate to contact me at (212) 450-4674 (tel), (212) 701-5674 (fax) or richard.truesdell@davispolk.com. Thank you for your time and attention. Very truly yours, /s/ Richard D. Truesdell, Jr. Richard D. Truesdell, Jr. cc: Mark E. Jones, Chairman and Chief Executive Officer of the Company Mark Colby, Chief Financial Officer of the Company P. Ryan Langston, Vice President and General Counsel of the Company Joshua Ford Bonnie, Simpson Thacher & Bartlett LLP William R. Golden III, Simpson Thacher & Bartlett LLP 2